410 related articles for article (PubMed ID: 32599435)
1. Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance.
Shahar N; Larisch S
Drug Resist Updat; 2020 Sep; 52():100712. PubMed ID: 32599435
[TBL] [Abstract][Full Text] [Related]
2. Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B.
van de Kooij B; Rooswinkel RW; Kok F; Herrebout M; de Vries E; Paauwe M; Janssen GM; van Veelen PA; Borst J
Oncogene; 2013 Nov; 32(48):5439-48. PubMed ID: 23563182
[TBL] [Abstract][Full Text] [Related]
3. A small-molecule ARTS mimetic promotes apoptosis through degradation of both XIAP and Bcl-2.
Mamriev D; Abbas R; Klingler FM; Kagan J; Kfir N; Donald A; Weidenfeld K; Sheppard DW; Barkan D; Larisch S
Cell Death Dis; 2020 Jun; 11(6):483. PubMed ID: 32587235
[TBL] [Abstract][Full Text] [Related]
4. Cancer and Apoptosis.
Chaudhry GE; Akim AM; Sung YY; Muhammad TST
Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
[TBL] [Abstract][Full Text] [Related]
5. Targeting BCL-2 regulated apoptosis in cancer.
Campbell KJ; Tait SWG
Open Biol; 2018 May; 8(5):. PubMed ID: 29769323
[TBL] [Abstract][Full Text] [Related]
6. IAPs as a target for anticancer therapy.
Danson S; Dean E; Dive C; Ranson M
Curr Cancer Drug Targets; 2007 Dec; 7(8):785-94. PubMed ID: 18220537
[TBL] [Abstract][Full Text] [Related]
7. Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.
Opferman JT
FEBS J; 2016 Jul; 283(14):2661-75. PubMed ID: 26293580
[TBL] [Abstract][Full Text] [Related]
8. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs).
Rathore R; McCallum JE; Varghese E; Florea AM; Büsselberg D
Apoptosis; 2017 Jul; 22(7):898-919. PubMed ID: 28424988
[TBL] [Abstract][Full Text] [Related]
9. Targeting XIAP for Promoting Cancer Cell Death-The Story of ARTS and SMAC.
Abbas R; Larisch S
Cells; 2020 Mar; 9(3):. PubMed ID: 32182843
[TBL] [Abstract][Full Text] [Related]
10. The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1).
Leja-Szpak A; Góralska M; Link-Lenczowski P; Czech U; Nawrot-Porąbka K; Bonior J; Jaworek J
Anticancer Agents Med Chem; 2019; 19(17):2079-2090. PubMed ID: 30987575
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors and Smac mimetics cooperate to induce cell death in diffuse large B-cell lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis.
Dietz A; Dalda N; Zielke S; Dittmann J; van Wijk SJL; Vogler M; Fulda S
Int J Cancer; 2020 Sep; 147(5):1485-1498. PubMed ID: 32170726
[TBL] [Abstract][Full Text] [Related]
12. Small molecules destabilize cIAP1 by activating auto-ubiquitylation.
Sekine K; Takubo K; Kikuchi R; Nishimoto M; Kitagawa M; Abe F; Nishikawa K; Tsuruo T; Naito M
J Biol Chem; 2008 Apr; 283(14):8961-8. PubMed ID: 18230607
[TBL] [Abstract][Full Text] [Related]
13. VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1.
Schache P; Gürlevik E; Strüver N; Woller N; Malek N; Zender L; Manns M; Wirth T; Kühnel F; Kubicka S
Gene Ther; 2009 Jul; 16(7):849-61. PubMed ID: 19369968
[TBL] [Abstract][Full Text] [Related]
14. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors.
Ashkenazi A; Fairbrother WJ; Leverson JD; Souers AJ
Nat Rev Drug Discov; 2017 Apr; 16(4):273-284. PubMed ID: 28209992
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
Richardson A; Kaye SB
Curr Mol Pharmacol; 2008 Nov; 1(3):244-54. PubMed ID: 20021437
[TBL] [Abstract][Full Text] [Related]
16. Nonlinear regulation of commitment to apoptosis by simultaneous inhibition of Bcl-2 and XIAP in leukemia and lymphoma cells.
Skommer J; Das SC; Nair A; Brittain T; Raychaudhuri S
Apoptosis; 2011 Jun; 16(6):619-26. PubMed ID: 21442307
[TBL] [Abstract][Full Text] [Related]
17. Altering protein turnover in tumor cells: new opportunities for anti-cancer therapies.
Demarchi F; Brancolini C
Drug Resist Updat; 2005 Dec; 8(6):359-68. PubMed ID: 16406769
[TBL] [Abstract][Full Text] [Related]
18. Targeting the B-cell lymphoma 2 anti-apoptotic proteins for cervical cancer treatment.
Abdul Rahman SF; Xiang Lian BS; Mohana-Kumaran N
Future Oncol; 2020 Oct; 16(28):2235-2249. PubMed ID: 32715755
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]